{"id":17151,"date":"2021-01-29T16:34:13","date_gmt":"2021-01-29T21:34:13","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=17151"},"modified":"2021-01-30T11:33:26","modified_gmt":"2021-01-30T16:33:26","slug":"01-25-21-01-29-21-ipo-summary","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/01-25-21-01-29-21-ipo-summary\/","title":{"rendered":"01.25.21-01.29.21 IPO Summary: IPOs Break amongst market volatility"},"content":{"rendered":"<p><!--more--><br \/>\n<a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-full wp-image-17162\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3.jpg\" alt=\"\" width=\"1650\" height=\"256\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3.jpg 1650w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3-600x93.jpg 600w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3-300x47.jpg 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3-1024x159.jpg 1024w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3-768x119.jpg 768w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Capture-3-1536x238.jpg 1536w\" sizes=\"(max-width: 1650px) 100vw, 1650px\" \/><\/a><\/p>\n<p>The headline for the financial markets this past week revolved around the &#8216;mania-stocks&#8217;&#8230; but the IPO felt the reverberations. In a week that had eight deals scheduled to debut, only two offerings opened above their issue price.\u00a0 Prior to this week, the IPO market had a perfect track record of positive debuts.<\/p>\n<p>The most heavily subscribed deals (and one&#8217;s we rated as a &#8216;4&#8217; out of &#8216;5&#8217; rating) both outperformed.<\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.42.44-PM.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-17035\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.42.44-PM-300x109.png\" alt=\"\" width=\"300\" height=\"109\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.42.44-PM-300x109.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.42.44-PM.png 434w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><strong>Qualtrics International Inc (XM)<\/strong>\u00a0priced\u00a050.4mm shares at $30.00\u00a0($1 Above the upwardly-revised $27-$29 range) and\u00a0<strong>opened at $41.85 for a gain of 39.5%.\u00a0 XM hit a high of $48.31\u00a0<\/strong>in its second session before closing the week at $44.00 &#8212; squarely ahead of its opening print.<\/p>\n<p><a href=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.35.03-PM.png\"><img decoding=\"async\" class=\"alignnone size-medium wp-image-17032\" src=\"http:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.35.03-PM-300x84.png\" alt=\"\" width=\"300\" height=\"84\" srcset=\"https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.35.03-PM-300x84.png 300w, https:\/\/www.ipoboutique.com\/blog\/wp-content\/uploads\/2021\/01\/Screen-Shot-2021-01-23-at-12.35.03-PM.png 348w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p>\n<p><strong><span style=\"font-family: Arial; font-size: large;\">Shoals Technology Group Inc (SHLS)\u00a0<\/span><\/strong><span style=\"font-family: Arial; font-size: large;\">priced\u00a0<\/span><span style=\"font-family: Arial; font-size: large;\">77.0mm shares\u00a0(upsized from 70.0mm)\u00a0at $25.00<\/span><span style=\"font-family: Arial; font-size: large;\"> ($2 above the upwardly-revised range) and\u00a0<\/span><strong><span style=\"font-family: Arial; font-size: large;\">opened at $31.30 for a gain of 25.2% at first trade. SHLS\u00a0<\/span><\/strong><span style=\"font-family: Arial; font-size: large;\">traded higher in its opening week and closed Friday&#8217;s session at $33.93.<\/span><\/p>\n<p>There ended up being five deals that opened at or below their respective issue prices and one that was postponed.<\/p>\n<p><strong>Ortho Clinical Diagnostics Holdings plc (OCDX)<\/strong>\u00a0priced\u00a0<strong>76.0mm shares<\/strong>\u00a0(upsized from 70.0mm)\u00a0<strong>at $17.00<\/strong>\u00a0($3.00 below the prevailing $20-$23 range) and\u00a0<strong>opened at $15.50 for a loss of 8.82%<\/strong><\/p>\n<p><strong>Vinci Partners Investments Ltd (VINP)\u00a0<\/strong>priced\u00a0<strong>13.9mm shares at $18.00<\/strong>\u00a0 and\u00a0<strong>opened at $17.70 for a loss of 1.7% at first trade.<\/strong><\/p>\n<p><strong>ZIM Integrated Shipping Services Ltd (ZIM)\u00a0<\/strong>priced\u00a014.5mm shares\u00a0(downsized from 17.5mm)\u00a0at $15.00\u00a0($1.00 below range) and\u00a0<strong>opened at $11.50 for a loss of 23.3%.\u00a0<\/strong><\/p>\n<p><strong>Home Point Capital Inc (HMPT)\u00a0<\/strong>priced<strong>\u00a07.25mm shares<\/strong>\u00a0(downsized from 12.5mm)\u00a0<strong>at $13.00<\/strong>\u00a0($6 below the $19-$21 range) and opened at $9.60 for a loss of 26.1% at first trade.<\/p>\n<p><strong>Trinity Capital Inc (TRIN)\u00a0<\/strong>priced\u00a0<strong>7.375mm shares at $14.00<\/strong>\u00a0(lower-half of range) and\u00a0<strong>opened at $14.00.\u00a0<\/strong><\/p>\n<div><strong>Southeastern Grocers, Inc. (SEGR)\u00a0<\/strong>did not price its offering. We are being told that the offering is\u00a0<strong>postponed due to market conditions<\/strong>. There is no further information available at this time.<\/div>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>Looking ahead to this week, there are currently seven IPOs scheduled to debut this week, however, we are hearing as many as seven biotech IPOs could launch and debut next week.<\/p>\n<p><span style=\"text-decoration: underline;\"><strong>Wednesday (2\/3) Debut<\/strong><\/span><\/p>\n<ul>\n<li><strong>On24 Inc.(ONTF)<\/strong> &#8212; <span style=\"font-weight: 400;\">They provide a leading, cloud-based digital experience platform that enables businesses to convert customer engagement into revenue through interactive webinar experiences, virtual event experiences and multimedia content experiences.<\/span><\/li>\n<li><strong>Telus International (Cda), Inc. (TIXT)<\/strong> &#8212; They are a leading digital customer experience innovator that designs, builds and delivers next-generation solutions for global and disruptive brands.<\/li>\n<\/ul>\n<p><span style=\"text-decoration: underline;\"><strong>Thursday (2\/4) Debut<\/strong><\/span><\/p>\n<ul>\n<li><strong>Atotech Limited (ATC)<\/strong> &#8212; They are the leading global provider of specialty electroplating solutions delivering chemistry, equipment, and service for high-growth technology applications.<\/li>\n<li><strong>Evaxion Biotech A\/S (EVAX)<\/strong> &#8212; \u00a0They are a clinical-stage AI-immunology\u2122 platform company using their proprietary artificial intelligence, or AI, technology, engineering expertise and drug development know-how to simulate the human immune system and generate predictive models to identify and develop novel immunotherapies for the treatment of various cancers, bacterial diseases and viral infections.<\/li>\n<li><strong>Loan Depot Inc. (LDI)<\/strong>\u00a0 &#8212; \u00a0\u00a0LoanDepot is a leading technology-enabled U.S. consumer lending platform.<\/li>\n<li><strong>Landos Biopharma Inc. (LABP)<\/strong> &#8212; <span style=\"font-weight: 400;\">\u00a0<\/span>They are a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases that are the first to target new mechanisms of action, including the LANCL2, NLRX1 and PLXDC2 immunometabolic pathways.according to the CIC report.<\/li>\n<li><strong>Sana Biotechnology Inc. (SANA)<\/strong> &#8212; They have long-term aspirations to be able to control or modify any gene in the body, to replace any cell that is damaged or missing, and to markedly improve access to cellular and gene-based medicines.<\/li>\n<\/ul>\n<p>Indicating for IPOs or Secondary offerings? Place IPO Boutique on your team.<\/p>\n<p><a href=\"https:\/\/www.ipoboutique.com\/blog\/register\/\"><strong>https:\/\/www.ipoboutique.com\/blog\/register\/<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":5,"featured_media":17018,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058],"tags":[2356,2357,2359,2358,2360,2361,1647,2362],"class_list":["post-17151","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","tag-hmpt","tag-ocdx","tag-segr","tag-shls","tag-trin","tag-vinp","tag-xm","tag-zim"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=17151"}],"version-history":[{"count":6,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17151\/revisions"}],"predecessor-version":[{"id":17170,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/17151\/revisions\/17170"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/17018"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=17151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=17151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=17151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}